We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program. Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.
Topline data from PORTOLA Phase 2a clinical trial evaluating zetomipzomib in patients with autoimmune hepatitis (AIH) expected in first half 2025 Cash, cash equivalents and marketable securities...
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.35 | -4.92957746479 | 7.1 | 7.1 | 6.72 | 43064 | 6.86109604 | CS |
4 | -0.7 | -9.39597315436 | 7.45 | 7.65 | 6.72 | 64090 | 7.19058774 | CS |
12 | 0.865 | 14.6983857264 | 5.885 | 9.18 | 5.016 | 765086 | 7.75415577 | CS |
26 | -0.383 | -5.3694097855 | 7.133 | 9.18 | 5.016 | 631341 | 7.04630041 | CS |
52 | -1.754 | -20.6255879586 | 8.504 | 11.35 | 5.016 | 652643 | 7.88037497 | CS |
156 | -129.85 | -95.0585651537 | 136.6 | 185.5 | 5.016 | 850005 | 53.91832676 | CS |
260 | -20.45 | -75.1838235294 | 27.2 | 185.5 | 5.016 | 688333 | 60.70766929 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions